Who are we?
A Virtual Networking and Research Collaboration Initiative in Cardiac Oncology
Multidisciplinary collaboration is invaluable in the treatment and management of cancer patients. The Canadian Cardiac Oncology Network was established to facilitate collaboration among health care professionals and researchers interested in the emerging field of cardiac oncology.
A Message from Dr. Dinesh Thavendiranathan
Cardiologist, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network
Associate Professor of Medicine, University of Toronto
Director, Ted Rogers Program in Cardiotoxicity Prevention
Canada Research Chair in Cardio-Oncology
Welcome to the Canadian Cardiac Oncology Network! We have made great strides in the treatment of cancer over the last decade. An increasing number of individuals are surviving a cancer diagnosis with the expectation of experiencing a good quality of life; however, some cancer therapies may have a negative effect on the heart. It is important that health care providers learn how to identify and manage these potential heart problems, to ensure that cancer patients are treated with the ‘best available’ cancer treatments.

 The Canadian Cardiac Oncology Network will serve to bring health care professionals together to discuss how we can optimize heart health while providing ‘state of the art’ cancer care. Education of both health care providers and the public is also an important part of this initiative and collaboration.
To optimize cardiac care for cancer patients receiving potentially cardiotoxic therapies.
1. Gain a better understanding of cardiac complications related to cancer treatments
2. Develop early detection and intervention strategies to optimize cardiac health
3. Optimize patient outcomes by collaborating with allied healthcare professionals
Cancer, the Heart, and CCON
Cancer and the heart are becoming common terminology in both oncology and cardiology practices. With the evolution of systemic and targeted therapies in cancer treatment, it has become increasingly evident that damage to the heart may occur as a result of cancer therapy. Although cardiac toxicities associated with conventional chemotherapy are well known, the short- and long-term effects of targeted agents on the heart are less well understood. The Canadian Cardiac Oncology Network was established in 2011 to bring together health care professionals interested in understanding how cancer therapies impact cardiac health. To date, we have hosted three Canadian Cardiac Oncology Network conferences in Ottawa, Ontario, with a growing interest from a number of health care providers including: oncologists, cardiologists, nurses, pharmacists, radiologists and basic scientists. The Canadian Cardiac Oncology Network has made great strides since its inception and has gained recognition from several academic institutions across North America.
Clinical Services
The goal of the clinical component of the program is the rapid assessment of cancer patients who are at risk of or have experienced cardiac toxicities from their cancer therapy.

The goal of the research component of the program is to develop a national cardiac oncology patient registry in order to facilitate the development of evidence based guidelines for diagnosis and treatment of cardiac toxicity in cancer patients.

The goal of the educational component of the program is to educate patients, practitioners, and health care professionals at various stages of training. Education activities will focus on producing electronic learning resources and the delivery of quarterly webinars , to foster education of health care professionals and trainees across the nation.
Board of Directors
Our philosophy is simple — hire a team of diverse, passionate people and foster a culture that empowers you to do you best work.
Dr. Dinesh Thavendiranathan
Vice President
Dr. Negareh Mousavi
Dr. Ian Paterson
Member at Large
Dr. Margot Davis

Dr. Christine Brezden-Masley
Founder & Past-President
Dr. Susan Dent
Patient Representative
Maya Stern

Dr. Kai Yi Wu

Allied Health
Professionals Representative
Amale Ghandour
Dr. Yared Kibar

Dr. Guillaume
St.Pierre (FR)
Clinical Lead
Dr. Raveen Pal
Clinical Lead
Dr. Moira Rushton
Education Lead
Dr. Michelle Nadler
Education Lead
Dr. Fernando
Research Lead
Dr. Husam Abdel-Qadir
Research Lead
Dr. Darryl Leong